Management of bleb-like retinal detachment in aggressive retinopathy of prematurity

Vishakh Padmakumar1, Harshitha K M1, Subhadra Jalali2

  • 1ABRI, LV Prasad Eye Institute, GMRV Campus, Visakhapatnam, Andhra Pradesh, India.

BMJ Case Reports
|January 22, 2025
PubMed

Insights

Bleb-like retinal detachment in retinopathy of prematurity is challenging. A combination of bevacizumab injections and vitrectomy surgery achieved good anatomical and visual success in a preterm infant.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Pediatric Surgery

Background:

  • Bleb-like retinal detachment (BLRD) in posterior zone 1 retinopathy of prematurity (ROP) poses significant therapeutic challenges.
  • ROP is a leading cause of childhood blindness, particularly in premature infants.
  • Zone 1 ROP is associated with a higher risk of aggressive disease and poor visual outcomes.

Purpose of the Study:

  • To present a case of successful management of bilateral stage 4 aggressive ROP with BLRD in posterior zone 1.
  • To discuss the risk factors, treatment challenges, and outcomes associated with BLRD in ROP.
  • To highlight the combined approach of intravitreal bevacizumab and lens-sparing vitrectomy.

Main Methods:

  • A preterm infant (1100 g) with bilateral stage 4 aggressive ROP in posterior zone 1 and BLRD was treated.
  • Bilateral intravitreal bevacizumab injections were administered.
  • Lens-sparing vitrectomy surgery was performed subsequently.

Main Results:

  • The infant tolerated both procedures well.
  • The initial postoperative course was uneventful.
  • Good anatomical and visual success was achieved postoperatively.

Conclusions:

  • A combined approach of intravitreal bevacizumab and lens-sparing vitrectomy can be effective for managing BLRD in aggressive ROP.
  • Early intervention and multimodal treatment strategies are crucial for improving visual prognosis in these complex cases.
  • Further research is warranted to establish optimal treatment protocols for BLRD in ROP.